Cellular and molecular mechanisms underlying LPS-associated myocyte impairment

Area of Science:

• Immunology
• Cardiovascular Biology
• Cellular Biology

Background:

• Toll-like receptor 4 (TLR4)-positive immune cells mediate lipopolysaccharide (LPS)-induced cardiac myocyte dysfunction.
• The specific identity of these TLR4-positive immune cells remained unknown.

Purpose of the Study:

• To identify the specific TLR4-positive immune cell type responsible for LPS-induced cardiac dysfunction.
• To elucidate the molecular mechanisms, including TNF-alpha and nitric oxide pathways, involved in this process.

Main Methods:

• Utilized neutrophil depletion, mast cell deficiency, and macrophage deficiency models in mice.
• Investigated the impact of combined neutrophil and macrophage depletion on cardiac function during LPS challenge.
• Examined knockout mice for inducible nitric oxide synthase (iNOS) and TNF receptors (TNFR1/TNFR2) following LPS treatment.

Main Results:

• Macrophage deficiency partially improved LPS-induced myocyte shortening impairment.
• Combined depletion of neutrophils and macrophages completely restored myocyte shortening.
• Elimination of both TNFR1 and TNFR2, but not iNOS deficiency, restored myocyte shortening.

Conclusions:

• Macrophages are the primary immune cells mediating LPS-induced cardiac dysfunction, with neutrophils playing a lesser role.
• Tumor necrosis factor-alpha (TNF-alpha) signaling via TNFR1 and TNFR2 is a key pathway in this cardiac impairment.
• These findings identify specific immune cell players and pathways contributing to endotoxemic cardiac dysfunction.